“a nonsignificant trend”

There was a nonsignificant trend towards improved survival for patients with GTR (HR = 0.62, P = .059) and significantly improved survival for patients receiving proton radiation (HR = 0.50, P = .019), but neither of these factors was associated with improved PFS.

There was a nonsignificant trend for a higher maximum VAS in the rooming‐in group (2.27 ± 1.80 vs. 2.34 ± 1.82, P = 0.0591).

cir‐CAFs cases showed a nonsignificant trend of correlation with CEA ( p = 0.0597).

There was only a nonsignificant trend to explain effect size variation by actual prone duration ( z = -1.88; P = 0.06).

This study reported a nonsignificant trend for patients receiving favipiravir to have a shorter hospital stay (13.29 days compared to 15.89 for CQ; P = 0.06) and less likelihood of progressing to mechanical ventilation ( P = 0.118) or to an oxygen saturation of <90% ( P = 0.129).

A nonsignificant trend suggested men rated nurse recommendations more positively than women ( χ 2 4 =5.54; P =.06), and younger adults rated overall program usefulness slightly higher ( χ 2 2 =4.87; P =.09).

Moreover, we observed a nonsignificant trend in the same direction in segment 2 ( p = .06).

There was a nonsignificant trend toward a higher 1-year all-cause mortality in patients with prior MI in the univariate analysis (17.4 vs. 13.7%, p = 0.06).

Albumin levels were also significantly lower in ICU-admitted patients ( P < 0.001), while a nonsignificant trend was observed between survivors and nonsurvivors ( P = 0.06).

According to the results of the univariable analyses, a creatinine concentration ≥ 0.86 mg/dL was significantly associated with AEs (OR 4.1, 95% CI 1.58–10.7; p = 0.0037), and the incidence of decompensated cirrhosis showed a nonsignificant trend (OR 3.15; p = 0.060).

There was a nonsignificant trend of ETP-positive cases to have lower overall survival (OS) ( P = 0.06).

We also observed a nonsignificant trend toward lower OCT use over IVUS with increasing operator age (OR = 0.93, 95% CI 0.73-1.00, P = 0.06; Supplemental Table S3 ).

There was a nonsignificant trend across weeks 1 and 6 toward greater glucose variability before 1200 in the breakfast group compared with the fasting group (treatment effect: F = 3.9, P = 0.06).

In contrast, more typical features of MDD (decreased appetite and body weight, probably including melancholia) exhibited a nonsignificant trend of negative correlation with BMI ( r g = −0.28, p = 0.06; Milaneschi et al. 2017 ).

The following predictors were found to be positively correlated with physiotherapy participation: patient expectations for recovery ( P =.007), self-efficacy ( P =.04), lower anxiety scores ( P =.03), and greater income ( P =.03).There was also a nonsignificant trend for greater physiotherapy participation in older patients ( P =.06).

A nonsignificant trend was observed for age (>50 v ≤50 years, 30% v 37.6%, P = .06).

There was a nonsignificant trend towards a lower incidence of peripheral sensory neuropathy (2.7% vs 9.0%, P =0.06).

There was no significant difference between genotypes in this measure prior to acute morphine exposure (Figure 1L ) ( t 14 = 1.13, p = 0.28) and a nonsignificant trend prior to morphine challenge (Figure 1M ) ( t 22 = 1.98, p = 0.06).

Serratia significantly reduced bee survival ( χ 2 = 10.84, p < 0.001), and there was a nonsignificant trend for such effects to be stronger in the absence of the core gut microbiome ( χ 2 = 3.53, p = 0.060; Figure 5a ), although there was no detectable main effect of core microbiome treatment ( χ 2 = 0.41, p = 0.503; Figure 5a ).

CGM demonstrated a nonsignificant trend toward reduced incidence of LGA (RR 0.81, 95% CI 0.65 to 1.01, P = 0.06, I2 = 31%) and neonatal hypoglycemia (RR 0.85, 95% CI 0.70 to 1.03, P = 0.10, I2 = 0%).

Other than a nonsignificant trend toward an association between H1v and a lower risk of PSP (OR = 0.44, P = 0.06), the H1b, H1r, and H1v haplotypes have not been associated with other neurodegenerative disorders with a similar clinical or neuropathological phenotype to PD, such as PSP, MSA, or DLB. 12 , 13 , 28 Though it will be important to validate the findings of our study, future studies examination associations of H1 subhaplotypes with clinical features of other neurodegenerative diseases will also be important.

However, in a subgroup of patients with a TG level in the upper third (≥204 mg/dL [≥2.30 mmol/L]) and an HDL-C level in the lower third (≤34 mg/dL [≤0.88 mmol/L]), there was a nonsignificant trend ( P =0.06) for reduction in cardiovascular risk. 84 Niacin Prescription strength niacin is indicated to reduce elevated total cholesterol, LDL-C, apoB, and TG levels and to increase HDL-C in patients with primary hyperlipidemia, severe hypertriglyceridemia, and mixed dyslipidemia.

Baseline ALT, AST and tBil in association with outcomes and changes in health status There was a nonsignificant trend toward an increased risk of death or HF hospitalization for patients with lower ALT levels: HR: 0.82 (95% CI: 0.66-1.01) per log increase, P = 0.06 ( Supplemental Figure 1 ; Central Illustration ).

There was a nonsignificant trend towards lower trait anxiety in ECT-treated vs sham-treated patients ( P= .06).

There was a nonsignificant trend suggesting that receiving social support moderated the association between COVID-19 impact and depressive symptoms, p = .06, such that greater COVID-19 impact was associated with more depressive symptoms among adolescents reporting receiving low social support, p = .007, but not adolescents reporting average or high social support, p ≥ .13.